GB2170407B - Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions - Google Patents

Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions

Info

Publication number
GB2170407B
GB2170407B GB08602602A GB8602602A GB2170407B GB 2170407 B GB2170407 B GB 2170407B GB 08602602 A GB08602602 A GB 08602602A GB 8602602 A GB8602602 A GB 8602602A GB 2170407 B GB2170407 B GB 2170407B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
containing compositions
ergot alkaloid
alkaloid containing
dihydro ergot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08602602A
Other languages
English (en)
Other versions
GB2170407A (en
GB8602602D0 (en
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8602602D0 publication Critical patent/GB8602602D0/en
Publication of GB2170407A publication Critical patent/GB2170407A/en
Priority to MYPI87002010A priority Critical patent/MY102906A/en
Application granted granted Critical
Publication of GB2170407B publication Critical patent/GB2170407B/en
Priority to MX9203583A priority patent/MX9203583A/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08602602A 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions Expired GB2170407B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI87002010A MY102906A (en) 1986-02-03 1987-09-28 Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions
MX9203583A MX9203583A (es) 1985-02-05 1992-06-26 Composicion farmaceutica de liberacion prolongada a base de 9,10-dihidro-alcaloides.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (3)

Publication Number Publication Date
GB8602602D0 GB8602602D0 (en) 1986-03-12
GB2170407A GB2170407A (en) 1986-08-06
GB2170407B true GB2170407B (en) 1988-10-26

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08602602A Expired GB2170407B (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions

Country Status (24)

Country Link
JP (1) JPS61183225A (da)
KR (1) KR920010388B1 (da)
AU (1) AU597570B2 (da)
BE (1) BE904152A (da)
CA (1) CA1263087A (da)
CH (1) CH667592A5 (da)
CY (1) CY1604A (da)
DE (1) DE3602577A1 (da)
DK (1) DK167138B1 (da)
ES (1) ES8800040A1 (da)
FR (1) FR2576787B1 (da)
GB (1) GB2170407B (da)
GR (1) GR860310B (da)
HK (1) HK57191A (da)
HU (1) HU195729B (da)
IE (1) IE59293B1 (da)
IT (1) IT1191255B (da)
LU (1) LU86289A1 (da)
NL (1) NL8600161A (da)
NZ (1) NZ215020A (da)
PH (1) PH23384A (da)
PT (1) PT81954B (da)
SE (1) SE8600496L (da)
SG (1) SG56191G (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
MXPA02005291A (es) * 1999-12-03 2004-06-21 Polichem Sa Metodos para elaborar composiciones farmaceuticas de liberacion sostenida de alcaloides de cornezuelo de centeno que tienen biodisponibilidad mejorada y composiciones de los mismos.
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
ES2299484T3 (es) 2000-05-12 2008-06-01 Meracol Corporation Limited Tratamiento del sindrome o enfermedad de intestino irritable.
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2001085163A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating eczema and/or psoriasis
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
SE8600496L (sv) 1986-08-06
KR920010388B1 (ko) 1992-11-27
IE59293B1 (en) 1994-02-09
AU5294286A (en) 1986-08-14
CY1604A (en) 1992-04-03
GB2170407A (en) 1986-08-06
IE860291L (en) 1986-08-05
DK167138B1 (da) 1993-09-06
PT81954A (en) 1986-03-01
SG56191G (en) 1991-08-23
NL8600161A (nl) 1986-09-01
CA1263087A (en) 1989-11-21
IT1191255B (it) 1988-02-24
GB8602602D0 (en) 1986-03-12
KR860006265A (ko) 1986-09-09
FR2576787A1 (fr) 1986-08-08
PT81954B (pt) 1988-07-01
GR860310B (en) 1986-05-27
HUT41984A (en) 1987-06-29
JPS61183225A (ja) 1986-08-15
HK57191A (en) 1991-08-02
PH23384A (en) 1989-07-26
AU597570B2 (en) 1990-06-07
SE8600496D0 (sv) 1986-02-04
DK52086D0 (da) 1986-02-03
ES8800040A1 (es) 1987-10-16
FR2576787B1 (fr) 1990-01-12
IT8647620A0 (it) 1986-02-05
CH667592A5 (de) 1988-10-31
ES551635A0 (es) 1987-10-16
DE3602577A1 (de) 1986-08-28
DK52086A (da) 1986-08-06
LU86289A1 (fr) 1986-09-02
NZ215020A (en) 1989-07-27
BE904152A (fr) 1986-08-04
HU195729B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
ZA877530B (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same as well as processes for production thereof
ZA859729B (en) New imidazo derivatives,the preparation thereof and pharmaceutical compositions containing these compounds
GB2109795B (en) Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
ZA859730B (en) Pharmaceutical compositions containing new imidazo derivatives
GB2110533B (en) Compositions containing alkaloid derivatives
GB2170407B (en) Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
IL79236A0 (en) Pharmaceutical compositions containing vitamin d derivatives
NZ216054A (en) Thieno (2,3-d)imidazole derivatives and pharmaceutical compositions
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
ZA85143B (en) Novel delta4-and delta5-androstene derivatives,processes for their preparation and pharmaceutical compositions containing these derivates
GB2173101B (en) Dopaminergic compositions containing dihydroergocryptine
IL86437A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
IL69450A0 (en) Ergot alkaloids,their production and pharmaceutical compositions containing them
IL91999A0 (en) Antiemesis pharmaceutical compositions containing ergoline derivatives
IL91482A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
GB2206491B (en) Anti-anxiogenic compositions containing dioxopiperidine derivatives
IL67883A0 (en) Ergot peptide alkaloids and their salts,their production and pharmaceutical compositions containing them
ZA862943B (en) 12b-substituted 1-hydroxymethyl-octahydroindolo-(2,3-a)quinolizine derivatives,process for their preparation and pharmaceutical compositions containing them
NZ221549A (en) Penicillin derivatives & pharmaceutical compositions
IL91480A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
ZA86848B (en) Pharmaceutical 9,-10-dihydrogenated ergot alkaloid containing compositions
IL84857A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
NZ226785A (en) Isoxazolo(4,5-c azepine derivatives and pharmaceutical compositions
IL75166A (en) 2-substituted spiro(1,3-oxathiolane-5,3-quinuclidine)derivatives,their preparation and pharmaceutical compositions containing them and 3-hydroxy-3-mercaptomethylquinuclidine as intermidiate therefor

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940203